$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 10, 2025)
$564.50M
Market Cap
19.28
P/E Ratio
0.18
EPS
$5.13
52 Week High
$0.52
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Ironwood Pharmaceuticals, Inc. is a prominent biotechnology firm headquartered in Boston, Massachusetts, specializing in the development and commercialization of innovative gastroenterological therapies. The company has a strong market presence driven by its flagship product, Linzess (linaclotide), and a robust pipeline aimed at addressing significant unmet medical needs in gastrointestinal disorders. Ironwood's strategic emphasis on research, development, and partnerships enhances its therapeutic offerings and positions it for sustainable growth, promising substantial long-term value for institutional investors while ultimately improving patient outcomes.
LPTX
VHAI
IRBT
NVDA
WOK
WBD
PLUG
ADAP
ASST
INTC
BYND
PLTR
ENVB
UBER
DNN
MTSR
AAL
SOFI
PLTD
HPE
NFLX
RGTI
RIG
TSLA
RKLB
CFLT
CGTL
BITF
DVLT
F
ADVB
CIFR
GPK
QBTS
WULF
KVUE
WRBY
GOOGL
JBLU
BLNK
CHWY
T
MSFT
BBGI
IREN
GRAB
VZ
HBAN
SHOT
RR
BAC
BTBT
PFE
ZAPP
MARA
NIO
SOLT
CVS
SMR
BDRX
COMP
RDW
PLAB
LPTX
VHAI
IRBT
NVDA
WOK
WBD
PLUG
ADAP
ASST
INTC
BYND
PLTR
ENVB
UBER
DNN
MTSR
AAL
SOFI
PLTD
HPE
NFLX
RGTI
RIG
TSLA
RKLB
CFLT
CGTL
BITF
DVLT
F
ADVB
CIFR
GPK
QBTS
WULF
KVUE
WRBY
GOOGL
JBLU
BLNK
CHWY
T
MSFT
BBGI
IREN
GRAB
VZ
HBAN
SHOT
RR
BAC
BTBT
PFE
ZAPP
MARA
NIO
SOLT
CVS
SMR
BDRX
COMP
RDW
PLAB